Opinion: It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough
30 November 2022
The new drug lecanemab shows promise to one day treat Alzheimer's disease, but there's still a long way to go before it can be an effective and easily available treatment, writes Professor Jonathan Schott (UCL Queen Square Institute of Neurology) in The Guardian.
![jon schott](https://www.ucl.ac.uk/ion/sites/ion/files/styles/large_image/public/jonschott8x5_0_1.jpg?itok=P6ADKm8R)